SIG
NVAX icon

Sargent Investment Group’s Novavax NVAX Stock Holding History

Sargent Investment Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-50,775
Closed -$437K – 241
2024
Q4 		$437K Buy
50,775
+9,940
+24% +$95.8K 0.07% 145
2024
Q3 		$516K Buy
40,835
+10,000
+32% +$129K 0.09% 115
2024
Q2 		$390K Buy
30,835
+11,250
+57% +$113K 0.08% 138
2024
Q1 		$93.6K Sell
19,585
-760
-4% -$3.52K 0.02% 194
2023
Q4 		$97.7K Sell
20,345
-4,900
-19% -$30K 0.02% 203
2023
Q3 		$183K Buy
+25,245
New +$202K 0.04% 192
2023
Q1 		– Sell
-14,205
Closed -$146K – 205
2022
Q4 		$146K Sell
14,205
-1,385
-9% -$24.4K 0.05% 182
2022
Q3 		$282K Sell
15,590
-6,036
-28% -$262K 0.09% 140
2022
Q2 		$1.11M Buy
21,626
+1,763
+9% +$91.3K 0.34% 63
2022
Q1 		$1.46M Sell
19,863
-137
-0.7% -$12.2K 0.37% 54
2021
Q4 		$2.86M Buy
20,000
+333
+2% +$57.2K 0.65% 39
2021
Q3 		$4.08M Sell
19,667
-980
-5% -$216K 0.99% 32
2021
Q2 		$4.38M Sell
20,647
-1,327
-6% -$243K 1.04% 28
2021
Q1 		$3.98M Sell
21,974
-1,534
-7% -$306K 1.05% 26
2020
Q4 		$2.62M Sell
23,508
-1,398
-6% -$149K 0.83% 30
2020
Q3 		$2.7M Sell
24,906
-13,153
-35% -$1.6M 0.98% 25
2020
Q2 		$3.03M Sell
38,059
-3,300
-8% -$126K 1.14% 22
2020
Q1 		$562K Buy
41,359
+22,900
+124% +$194K 0.26% 74
2019
Q4 		$73K Sell
18,459
-2,227
-11% -$9.66K 0.03% 151
2019
Q3 		$104K Sell
20,686
-10,025
-33% -$54.9K 0.05% 137
2019
Q2 		$180K Buy
30,711
+1,307
+4% +$10.3K 0.08% 138
2019
Q1 		$324K Buy
29,404
+7,585
+35% +$239K 0.16% 104
2018
Q4 		$803K Buy
+21,819
New +$846K 0.49% 49

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sargent Investment Group's NVAX Position: Q1 2025 in Review

Sargent Investment Group sold out of Novavax (NVAX) in Q1 2025, closing a stake of 50,775 shares — an estimated $437K sold.

Sargent Investment Group first reported a position in NVAX in Q4 2018 and held it in 23 quarters. The position peaked at $4.38M in Q2 2021. 246 funds tracked by Wall St. Rank hold NVAX as of Q1 2025.

  • Sargent Investment Group reported no remaining Novavax position as of Q1 2025 after selling out during the quarter.
  • Sargent Investment Group sold 50,775 Novavax shares in Q1 2025, an estimated $437K.
  • Sargent Investment Group first reported a position in Novavax in Q4 2018 and held it in 23 quarters.
  • Sargent Investment Group's Novavax position peaked at $4.38M in Q2 2021.
  • 246 funds tracked by Wall St. Rank held Novavax as of Q1 2025.

Based on Sargent Investment Group's 13F filing for Q1 2025, filed 5 May 2025.